European Archives - Page 774 of 1345 - European Medical Journal

EMJ 6.3 2021 Feature Image

Review of Rifaximin: A Summary of the Current Evidence and Benefits Beyond Licensed Use

The benefits of rifaximin use continues to gather momentum, given its well-tolerated side-effect profile, and these require consideration.

EMJ 6.3 2021 Feature Image

Which Biologic Therapies to Treat Active Rheumatoid Arthritis and When?

The arrival of biologic disease-modifying anti-arthritis drugs (bDMARD) has vastly improved the outcomes of patients

EMJ 6.3 2021 Feature Image

Cardio-Metabolic Benefits of Walnuts in Type 2 Diabetes Mellitus: A Literature Review

In the USA, diabetes is a public health problem of epidemic proportions..

EMJ 6.3 2021 Feature Image

A Case Report of Extensively Drug Resistant Typhoid in Karachi, Pakistan: A Major Health Concern to Curb the Outbreak

Salmonella typhi is a flagellated gram-negative bacterium that is rod shaped

From Professional to Patient

Jonathan is joined by Dr Chris Streather, Group Chief Medical Officer, Deputy CEO, London’s Royal Free Hospital. They explore the potential of integrated care systems, offer their professional and personal perspectives on what makes a great leader, and Dr Streather shares his personal story of recently becoming a patient after suffering from a stroke.

Prostate-Specific Membrane Antigen PET Plus MRI Accurately Detects Prostate Cancer

COMBINING MRI with prostate-specific membrane antigen (PSMA) PET has been found to improve the detection of clinically significant…

A Novel Urine Biopsy May Aid Diagnosis and Treatment of Tumours in Bladder Cancer

URINE biopsies could form the basis of a faster and less invasive method to diagnose and monitor tumour growth in bladder cancer…

Carol Ross on corporate responsibility

Carol Lynch, Chief Business Officer, Sandoz, talks about how to increase the number of women in leadership positions in pharma and more.

Post-COVID-19 Pulmonary Fibrosis: Report of Two Cases

The authors report two cases of COVID-19 pneumonia with respiratory failure who were cured but developed pulmonary fibrosis with restrictive lung disease in the follow-up period.

Venetoclax with Chemotherapy Promising in Newly Diagnosed Patients with Acute Myeloid Leukaemia

THE ADDITION of venetoclax to intensive chemotherapy in young, fit patients with newly diagnosed acute myeloid leukaemia (AML) has been…